Zobrazeno 1 - 10
of 346
pro vyhledávání: '"Vaccine-induced immune thrombotic thrombocytopenia"'
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss 4, Pp 516-523 (2024)
Detecting anti-PF4 antibodies remains the golden diagnostic method for heparin-induced thrombocytopenia (HIT) diagnosis with high sensitivity and specificity. Various lab tests detect anti-PF4 antibodies, including immunoassays and functional assays.
Externí odkaz:
https://doaj.org/article/06fc1191e4c34e56932a5b69a27ff795
Publikováno v:
Bleeding, Thrombosis and Vascular Biology, Vol 3, Iss 2 (2024)
Anti-platelet factor 4 (PF4) disorders are a group of platelet-consumptive disorders characterized by platelet-activating antibodies against PF4, thrombocytopenia and an increased risk of thrombosis. PF4 is a chemokine released by platelet alpha gran
Externí odkaz:
https://doaj.org/article/7e05b1046e63477c9f8704c9d8f668c3
Management and Characteristics of Embolism and Thrombosis After COVID-19 Vaccination: Scoping Review
Publikováno v:
Journal of Multidisciplinary Healthcare, Vol Volume 16, Pp 2745-2772 (2023)
Lalipat Phianhasin,1,* Suebsarn Ruksakulpiwat,1 Suratsawadee Kruahong,1 Premgamon Kuntajak,1 Glenda B Kelman,2 Chitchanok Benjasirisan1,* 1Faculty of Nursing, Mahidol University, Bangkok, Thailand; 2Department of Nursing, Russell Sage College
Externí odkaz:
https://doaj.org/article/d9a067ffda9943e8803f97a77334debf
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
Externí odkaz:
https://doaj.org/article/ea51d2ecce9f44a3bf2450ca31b1a72d
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
Coronavirus disease 2019 (COVID-19), which was caused by the coronavirus - severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was globally responsible for remarkable morbidity and mortality. Several highly effective vaccines for COVID-19 w
Externí odkaz:
https://doaj.org/article/ffc09fd069c94b21bd7dafa43a52b4fb
Autor:
Shweta Parakh, Shrey Maheshwari, Shrutanjoy Das, Hans Vaish, Gaurav Luthra, Rupesh Agrawal, Vishali Gupta, Saurabh Luthra
Publikováno v:
Journal of Ophthalmic Inflammation and Infection, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Purpose To report a case of central retinal vein occlusion (CRVO) seven days following the first dose of ChAdOx1 nCoV-19 vaccine and propose a hypothesis for the possible underlying pathogenesis. Observation A 31-year-old male presented with
Externí odkaz:
https://doaj.org/article/8f64306bae994161a0dea3537f07601f
Publikováno v:
Microorganisms, Vol 12, Iss 3, p 435 (2024)
SARS-CoV-2 virulence is known to increase with lowering of environmental temperature and solar ultraviolet radiation; therefore, we have focused our real-world nationwide study concerning with COVID-19 trend and dynamics on the coldest seasons of the
Externí odkaz:
https://doaj.org/article/67eb0f844da44e6abb11aede76847e61
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Exploration of Immunology, Vol 2, Iss 4, Pp 604-621 (2022)
In ultrarare cases, patients vaccinated with DNA adenovirus vector vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), develop a vaccine-induced immune thrombotic thrombocytopenia (VITT), with a high incidence of fatal cases
Externí odkaz:
https://doaj.org/article/2cf6c580f49e484abe47a894aee1d2ec
Publikováno v:
Platelets, Vol 33, Iss 5, Pp 797-800 (2022)
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare and life-threatening complication that can occur after COVID-19 vaccination. After the first reports of VITT and CVST in 2021 after Ad26.COV2.S vaccination, the FDA and CDC recommend
Externí odkaz:
https://doaj.org/article/7724078aad6a4b7298bdc63bf7bac2cf